GSP
ELV icon

Grafton Street Partners’s Elevance Health ELV Stock Holding History

Grafton Street Partners’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.1M Sell
41,691
-6,262
-13% -$2.32M 8.9% 6
2026
Q1 		$14M Sell
47,953
-29,591
-38% -$9.73M 8.39% 6
2025
Q4 		$27.2M Hold
77,544
– – 13.31% 2
2025
Q3 		$25.1M Buy
77,544
+46,329
+148% +$14.4M 13.5% 3
2025
Q2 		$12.1M Hold
31,215
– – 7.67% 7
2025
Q1 		$13.6M Hold
31,215
– – 10.43% 5
2024
Q4 		$11.5M Buy
+31,215
New +$13.1M 8.37% 6

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Grafton Street Partners's ELV Position: Q2 2026 in Review

Grafton Street Partners reduced its Elevance Health (ELV) stake by 13% in Q2 2026, selling an estimated $2.32M and leaving 41,691 shares worth $16.1M. The position accounts for 8.9% of the portfolio, ranked #6.

Grafton Street Partners first reported a position in ELV in Q4 2024 and has held it in 7 quarters since. The position peaked at $27.2M in Q4 2025. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Grafton Street Partners held 41,691 shares of Elevance Health worth $16.1M as of Q2 2026.
  • Grafton Street Partners sold 6,262 Elevance Health shares in Q2 2026, an estimated $2.32M.
  • Elevance Health made up 8.9% of Grafton Street Partners's portfolio in Q2 2026, its #6 holding.
  • Grafton Street Partners first reported a position in Elevance Health in Q4 2024 and has held it in 7 quarters since.
  • Grafton Street Partners's Elevance Health position peaked at $27.2M in Q4 2025.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Grafton Street Partners's 13F filing for Q2 2026, filed 14 Aug 2026.